Duke Cancer Center Cary ( Site 0010) — Cary, North Carolina

Duke Cancer Center Cary ( Site 0010) is a clinical research site located in Cary, North Carolina, United States 27511.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Cancer Center Cary ( Site 0010) has participated in 1 clinical trials.

Therapeutic areas: Prostatic Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center Cary ( Site 0010)?

Duke Cancer Center Cary ( Site 0010) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center Cary ( Site 0010) conducted?

Duke Cancer Center Cary ( Site 0010) has 1 clinical trials on record. Their work covers Prostatic Neoplasms.

Is Duke Cancer Center Cary ( Site 0010) accredited by Crixeo Health?

Duke Cancer Center Cary ( Site 0010) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Center Cary ( Site 0010)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.